Published in Neurology on March 10, 2009
Vision and vision-related outcome measures in multiple sclerosis. Brain (2014) 1.08
The clinical characteristics of optic neuritis in Korean children. Korean J Ophthalmol (2011) 0.90
Pediatric multiple sclerosis. Ann Indian Acad Neurol (2009) 0.84
Optic neuritis in pediatric population: a review in current tendencies of diagnosis and management. J Optom (2014) 0.78
Parent and medical professional willingness to enroll children in a hypothetical pediatric optic neuritis treatment trial. Front Neurol (2011) 0.75
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology (2007) 4.72
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 3.21
Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med (1993) 2.97
Impact of color blindness on recognition of blood in body fluids. Arch Intern Med (2001) 2.78
Optical coherence tomography and disease subtype in multiple sclerosis. Neurology (2007) 2.56
The King-Devick test as a determinant of head trauma and concussion in boxers and MMA fighters. Neurology (2011) 2.51
Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology (2006) 2.17
MRI findings in Susac's syndrome. Neurology (2003) 2.17
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL. Neurology (2007) 2.17
The clinical spectrum of unruptured intracranial aneurysms. Arch Neurol (1993) 2.11
Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation (1997) 2.04
Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation (1991) 1.96
Relation of vision to global and regional brain MRI in multiple sclerosis. Neurology (2007) 1.89
Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology (2009) 1.78
Role of myelin P0 protein as a homophilic adhesion molecule. Nature (1990) 1.68
Purification and expansion of human Schwann cells in vitro. Nat Med (1995) 1.63
New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis. Mult Scler (2000) 1.60
The central visual field in homonymous hemianopia. Evidence for unilateral foveal representation. Arch Neurol (1997) 1.59
Associations between retinal nerve fiber layer abnormalities and optic nerve examination. Neurology (2010) 1.49
Monocytoid B-cell lymphoma. Am J Surg Pathol (1989) 1.47
Relative afferent pupillary defect with normal visual function. Arch Ophthalmol (1990) 1.47
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite. Neurology (2003) 1.46
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology (2007) 1.45
Isolated trochlear nerve palsy in patients with multiple sclerosis. Neurology (1999) 1.45
Visual impairment associated with mutism after posterior fossa surgery in children. Neurosurgery (1998) 1.44
Sixth nerve palsy as a presenting sign of intracranial plasmacytoma and multiple myeloma. J Neuroophthalmol (2000) 1.43
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology (2005) 1.43
CD20 is a molecular target for scFvFc:zeta receptor redirected T cells: implications for cellular immunotherapy of CD20+ malignancy. Biol Blood Marrow Transplant (1998) 1.42
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology (2000) 1.42
Choline acetyltransferase activity in striatum of neonatal rats increased by nerve growth factor. Science (1985) 1.41
Clinicopathologic study of paraneoplastic brainstem encephalitis and ophthalmoparesis. J Neuroophthalmol (1996) 1.39
Identifying high yield sources of patients with coronary artery disease for clinical trials: lessons from the Asymptomatic Cardiac Ischemia Pilot (ACIP) experience. The ACIP Study Group. Clin Cardiol (1998) 1.39
Is there an increased clinical severity of patients with eating disorders under managed care? J Adolesc Health (1999) 1.38
Cyclodeviation in skew deviation. Am J Ophthalmol (1994) 1.38
Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol (2001) 1.31
Early commitment of neural substrates for face recognition. Cogn Neuropsychol (2000) 1.31
Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum (1997) 1.30
Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons. Brain Res (1986) 1.30
Ross syndrome plus: beyond horner, Holmes-Adie, and harlequin. Neurology (2000) 1.29
Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology (1999) 1.29
Neuregulin signaling through a PI3K/Akt/Bad pathway in Schwann cell survival. Mol Cell Neurosci (2001) 1.24
Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity. J Neurol Neurosurg Psychiatry (2009) 1.22
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival. Leukemia (2010) 1.20
Erythrocyte deformability in uremic hemodialyzed patients. Ann Intern Med (1973) 1.17
Assessing disability progression with the Multiple Sclerosis Functional Composite. Mult Scler (2009) 1.15
The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the coronary drug project. Circulation (1982) 1.14
A role for Pak protein kinases in Schwann cell transformation. Proc Natl Acad Sci U S A (1998) 1.14
Surgeons and general practitioners--do they ever meet? Clin Oncol (1984) 1.13
Endovascular thrombolysis for symptomatic cerebral venous thrombosis. J Neurosurg (1999) 1.12
Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group. J Am Coll Cardiol (1992) 1.12
Left ventricular, peripheral vascular, and neurohumoral responses to mental stress in normal middle-aged men and women. Reference Group for the Psychophysiological Investigations of Myocardial Ischemia (PIMI) Study. Circulation (1996) 1.08
Neurofibromatosis type 1. I. General overview. J Neurosci Res (2000) 1.07
Crossed cerebellar atrophy in the Dyke-Davidoff-Masson syndrome. Neuroradiology (1992) 1.06
Refractory giant cell arteritis with spinal cord infarction. Neurology (1997) 1.05
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a. Neurology (2009) 1.05
Isolation of rat Schwann cell lines: use of SV40 T antigen gene regulated by synthetic metallothionein promoters. Exp Cell Res (1989) 1.04
Orbital drainage from cerebral arteriovenous malformations. Neurosurgery (2000) 1.04
The crossed paralyses. The original brain-stem syndromes of Millard-Gubler, Foville, Weber, and Raymond-Cestan. Arch Neurol (1995) 1.02
Pupil-involving third-nerve palsy and carotid stenosis: rapid recovery following endarterectomy. Ann Neurol (1997) 1.02
Delayed peripartum vasculopathy: cerebral eclampsia revisited. Ann Neurol (1993) 1.01
Sixth nerve palsies in children. Pediatr Neurol (1999) 1.01
The Psychophysiological Investigations of Myocardial Ischemia (PIMI) study: objective, methods, and variability of measures. Psychosom Med (1998) 1.00
Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II. Circulation (1992) 1.00
Herpes zoster ophthalmicus with orbital pseudotumor syndrome complicated by optic nerve infarction and cerebral granulomatous angiitis: MR-pathologic correlation. AJNR Am J Neuroradiol (1993) 0.99
Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring. Biol Blood Marrow Transplant (2000) 0.99
Pharmacological actions and clinical use of fructus schizandrae. Chin Med J (Engl) (1989) 0.98
Use of a portable head mounted perimetry system to assess bedside visual fields. Br J Ophthalmol (2000) 0.98
Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Leukemia (2010) 0.97
Anti-oxidant activity of dibenzocyclooctene lignans isolated from Schisandraceae. Planta Med (1992) 0.96
Horizontal homonymous sectoral field defect after ischemic infarction of the occipital cortex. Am J Ophthalmol (1990) 0.96
Homophilic adhesion of the myelin P0 protein requires glycosylation of both molecules in the homophilic pair. J Cell Biol (1993) 0.96
Role of nitric oxide in immunological liver damage in mice. Biochem Pharmacol (1995) 0.95
Intensive care neurology. Curr Opin Neurol (1994) 0.95
Induction of mutagenesis and transformation by the extract of Alternaria alternata isolated from grains in Linxian, China. Carcinogenesis (1987) 0.95
[Effect of bicyclol on acetaminophen-induced hepatotoxicity: energetic metabolism and mitochondrial injury in acetaminophen-intoxicated mice]. Yao Xue Xue Bao (2001) 0.95
Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial. Am J Cardiol (1988) 0.95
Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant (2003) 0.94
Morning glory disc anomaly and moyamoya vessels. Arch Ophthalmol (1998) 0.94
Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology (2011) 0.94